Azitra shares surge 18.16% premarket after NYSE American approves compliance plan granting compliance extension to 2027.

Azitra surged 18.16% in premarket trading after receiving NYSE American approval of its compliance plan to address the $4.0 million stockholders’ equity requirement. The exchange granted Azitra until April 1, 2027, to regain compliance, reducing immediate delisting risks and allowing continued listing during the period. The approval, coupled with a $1.5 million private placement at a premium to market, signaled progress in addressing liquidity concerns and bolstering investor confidence. The news directly aligns with the stock’s sharp premarket rise, as the compliance extension and funding efforts mitigate regulatory uncertainty, a.